Becher PM et al (2022) An update on global epidemiology in heart failure. Eur Heart J 43(32):3005–3007

Article  PubMed  Google Scholar 

Santhanakrishnan R et al (2016) Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation 133(5):484–492

Article  PubMed  PubMed Central  Google Scholar 

Savarese G et al (2023) Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res 118(17):3272–3287

Article  PubMed  Google Scholar 

Kotecha D et al (2016) Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins. J Am Coll Cardiol 68(20):2217–2228

Article  PubMed  Google Scholar 

Liu G et al (2021) Meta-analysis of atrial fibrillation and outcomes in patients with heart failure and preserved ejection fraction. Heart Lung Circ 30(5):698–706

Article  CAS  PubMed  Google Scholar 

Di Biase L et al (2016) Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device. Circulation 133(17):1637–1644

Article  PubMed  Google Scholar 

Marrouche Nassir F et al (2018) Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378(5):417–427

Article  CAS  PubMed  Google Scholar 

Michael RM et al (2011) Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart 97(9):740

Article  Google Scholar 

Prabhu S et al (2017) Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study. J Am Coll Cardiol 70(16):1949–1961

Article  PubMed  Google Scholar 

Tzeis S et al (2024) European heart rhythm association/heart rhythm society/Asia pacific heart rhythm society/latin American heart rhythm society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace 26(4):euae043. https://doi.org/10.1093/europace/euae043

Article  PubMed  PubMed Central  Google Scholar 

Tsang TSM et al (2002) Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 40(9):1636–1644

Article  PubMed  Google Scholar 

Santhanakrishnan R et al (2016) Atrial fibrillation begets heart failure and vice versa. Circulation 133(5):484–492

Article  PubMed  PubMed Central  Google Scholar 

Oraii A et al (2024) Atrial fibrillation ablation in heart failure with reduced vs preserved ejection fraction: a systematic review and meta-analysis. JAMA Cardiol 9(6):545–555. https://doi.org/10.1001/jamacardio.2024.0675

Article  PubMed  Google Scholar 

Matthew JP et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71

Google Scholar 

Mahalleh M et al (2024) Atrial Fibrillation Ablation Compared with Conventional Medical Therapies in Heart Failure With Preserved Ejection Fraction. PROSPERO 2024 CRD42024540195 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024540195. Accessed 13 May 2024

Gotschall T (2021) EndNote 20 desktop version. J Med Libr Assoc 109(3):520–522. https://doi.org/10.5195/jmla.2021.1260

Article  PubMed  PubMed Central  Google Scholar 

Julian PTH et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928

Article  Google Scholar 

Sterne JAC et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https://doi.org/10.1136/bmj.l4898

Article  PubMed  Google Scholar 

Sterne JA et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919

Article  PubMed  PubMed Central  Google Scholar 

Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748

CAS  PubMed  Google Scholar 

Robins J, Greenland S, Breslow NE (1986) A general estimator for the variance of the Mantel-Haenszel odds ratio. Am J Epidemiol 124(5):719–723

Article  CAS  PubMed  Google Scholar 

Knapp G, Hartung J (2003) Improved tests for a random effects meta-regression with a single covariate. Stat Med 22(17):2693–2710

Article  PubMed  Google Scholar 

Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558

Article  PubMed  Google Scholar 

Cochran WG (1954) Some methods for strengthening the common χ2 tests. Bioethics 10:417

Google Scholar 

R Core Team (2021). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL: https://www.R-project.org/. Accessed 13 May 2024

Wickham H et al (2019) Welcome to the tidyverse. J Open Source Software 4:1686

Article  Google Scholar 

Balduzzi S, Rücker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 22(4):153–160

Article  PubMed  PubMed Central  Google Scholar 

Parkash R et al (2022) Randomized ablation-based rhythm-control versus rate-control trial in patients with heart failure and atrial fibrillation: results from the RAFT-AF trial. Circulation 145(23):1693–1704

Article  CAS  PubMed  Google Scholar 

von Olshausen G et al (2022) Catheter ablation for patients with atrial fibrillation and heart failure: insights from the Swedish Heart Failure Registry. Eur J Heart Fail 24(9):1636–1646

Article  Google Scholar 

Rattka M et al (2021) Catheter ablation for atrial fibrillation in HFpEF patients-a propensity-score-matched analysis. J Cardiovasc Electrophysiol 32(9):2357–2367

Article  PubMed  Google Scholar 

Tsuda T et al (2023) Effect of catheter ablation for atrial fibrillation in heart failure with mid-range or preserved ejection fraction- pooled analysis of the AF Frontier Ablation Registry and Hokuriku-Plus AF Registry. Circ J 87(7):939–946

Article  CAS  PubMed  Google Scholar 

Xie Z et al (2023) Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fraction. Europace 26(1):euad363. https://doi.org/10.1093/europace/euad363

Article  PubMed  PubMed Central  Google Scholar 

Arora S et al (2020) Catheter ablation for atrial fibrillation in patients with concurrent heart failure. Am J Cardiol 137:45–54

Article  PubMed  Google Scholar 

Chieng D et al (2023) Atrial fibrillation ablation for heart failure with preserved ejection fraction: a randomized controlled trial. JACC Heart Fail 11(6):646–658

Article  PubMed  Google Scholar 

Packer DL et al (2021) Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial. Circulation 143(14):1377–1390

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huerta A et al (2016) Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism. J Hypertens 34(1):130–138

Article  CAS  PubMed  Google Scholar 

Tsuda T, et al (2022) Effect of catheter ablation for atrial fibrillation in heart failure with mid-range or preserved ejection fraction― pooled analysis of the AF Frontier Ablation Registry and Hokuriku-Plus AF Registry ―. Circulation Journal. advpub.

Xie Z, et al (2024) Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fraction. EP Europace. 26(1): p. euad363.

Packer DL et al (2021) Ablation versus drug therapy for atrial fibrillation in heart failure. Circulation 143(14):1377–1390